Reading time: approximately 10 minutes TL;DR: A 2026 narrative review in Medical Gas Research identifies four areas where AI is reshaping hyperbaric oxygen therapy: protocol...
TL;DR: Hyperbaric oxygen therapy (HBOT) is the only definitive treatment for acute decompression sickness (DCS) and arterial gas embolism (AGE). The 2024-2026 evidence base reinforces...
Reading time: about 11 minutes. Audience: Canadian referring physicians and emergency clinicians. TL;DR: Hyperbaric oxygen therapy (HBOT) is a Health Canada and UHMS recognised treatment...
TL;DR: Hyperbaric oxygen therapy (HBOT) has been investigated for multiple sclerosis (MS) since the early 1980s, but the randomised evidence base is dominated by twelve...
TL;DR: Hyperbaric oxygen therapy (HBOT) is not a Health Canada-approved indication for hair growth, hair loss, or alopecia of any cause. Evidence tier: D (preliminary...
TL;DR: Hyperbaric oxygen therapy (HBOT) is a regulated medical treatment in which patients breathe 100 percent oxygen inside a pressurised chamber, typically at 2.0 to...
TL;DR: Central retinal artery occlusion (CRAO) is an ophthalmic stroke that causes sudden painless monocular vision loss. Hyperbaric oxygen therapy (HBOT) is a Class IIb...
TL;DR: Sudden sensorineural hearing loss is a medical emergency. Hyperbaric oxygen therapy, added to steroid treatment within the first two weeks, is associated with about...
TL;DR: Hyperbaric oxygen therapy (HBOT) is being studied as a potential intervention for cellular aging. Evidence tier: C-to-D. Single uncontrolled trial (Hachmo 2020, n=35, no...